Literature DB >> 15361939

Drug resistance pattern of Mycobacterium tuberculosis in a university hospital in Taiwan, 1998-2002.

Yuang-Shuang Liaw1, Po-Ren Hsueh, Chong-Jen Yu, Shu-Kuang Wang, Pan-Chyr Yang, Kwen-Tay Luh.   

Abstract

BACKGROUND AND
PURPOSE: During 1998-2002, most specialized tuberculosis (TB) hospitals in Taiwan were closed; as a result, more TB patients are being managed in general hospital settings. This study investigated the prevalence, patterns and risk factors of drug-resistant Mycobacterium tuberculosis at a university hospital in the 5 years after decentralization of the TB administrative and clinical control infrastructure which occurred during the implementation of the national health insurance system in Taiwan.
METHODS: A total of 1411 initial isolates of M. tuberculosis from specimens collected during January 1998 through December 2002 were tested for drug susceptibility of first-line anti-TB drugs using the agar proportional method.
RESULTS: The numbers of newly diagnosed culture-positive TB patients increased from 139 in 1998 to 380 in 2002. The drug resistance pattern of M. tuberculosis among these isolates was as follows: 268 (19.0%) strains were resistant to isoniazid, 86 (6.1%) to rifampin, 221 (15.7%) to ethambutol, 141 (10.0%) to streptomycin, and 430 (30.5%) to 1 of these 4 drugs. Multidrug resistance (MDR), i.e., resistance to at least rifampin and isoniazid, was observed in 72 isolates (5.1%). Of the 1411 patients, isolates from patients with age < 65 years had a higher multiple drug resistance rate than those from patients with age > or = 65 years (57/781, 7.3% vs 15/630, 2.4%; p < 0.001). In the analysis of risk factors for MDR, patients with MDR isolates had a significantly higher incidence of previous TB history, anti-TB therapy, longer duration of symptoms, cavitary lesions in chest X-ray, and mortality.
CONCLUSION: A dramatic increase in cases of TB among patients treated at this university hospital was seen after the decentralization of the TB control infrastructure in Taiwan. The prevalence of drug resistance in isolates from culture-positive TB patients was 30.5% and the prevalence of MDR was 5.1%.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361939

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  10 in total

1.  Genetic diversity of multidrug-resistant Mycobacterium tuberculosis isolates and identification of 11 novel rpoB alleles in Taiwan.

Authors:  Ruwen Jou; Huang-Yau Chen; Chen-Yuan Chiang; Ming-Chih Yu; Ih-Jen Su
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

2.  Survey of medication knowledge and behaviors among college students in Taiwan.

Authors:  Fei-Yuan Hsiao; Jen-Ai Lee; Weng-Foung Huang; Shih-Ming Chen; Hsiang-Yin Chen
Journal:  Am J Pharm Educ       Date:  2006-04-15       Impact factor: 2.047

Review 3.  Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates.

Authors:  Helen E Jenkins; Arielle W Tolman; Courtney M Yuen; Jonathan B Parr; Salmaan Keshavjee; Carlos M Pérez-Vélez; Marcello Pagano; Mercedes C Becerra; Ted Cohen
Journal:  Lancet       Date:  2014-03-24       Impact factor: 79.321

4.  Declining drug resistance of Mycobacterium tuberculosis isolates from elderly patients in Taiwan, 2000-2008.

Authors:  W-L Liu; C-C Lai; C-K Tan; S-H Lin; Y-T Huang; C-H Liao; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-22       Impact factor: 3.267

5.  Clinical and microbiological characteristics of urine culture-confirmed genitourinary tuberculosis at medical centers in Taiwan from 1995 to 2007.

Authors:  H-L Hsu; C-C Lai; M-C Yu; F-L Yu; J-C Lee; C-H Chou; C-K Tan; P-C Yang; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-15       Impact factor: 3.267

6.  Primary Drug-Resistance Pattern and Trend in Elderly Tuberculosis Patients in Shandong, China, from 2004 to 2019.

Authors:  Qiqi An; Wanmei Song; Jinyue Liu; Ningning Tao; Yao Liu; Qianyun Zhang; Tingting Xu; Shijin Li; Siqi Liu; Yifan Li; Chunbao Yu; Huaichen Li
Journal:  Infect Drug Resist       Date:  2020-11-13       Impact factor: 4.003

7.  Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006.

Authors:  Travis C Porco; Peter Oh; Jennifer M Flood
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

8.  Effective interventions and decline of antituberculosis drug resistance in Eastern Taiwan, 2004-2008.

Authors:  Yi-Ting Chen; Jen-Jyh Lee; Chen-Yuan Chiang; Gee-Gow Yang; Yeong-Chu Tsai; Yeong-Sheng Lee; Chih-Bin Lin
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

9.  Drug-resistant Mycobacterium tuberculosis, Taiwan.

Authors:  Ruwen Jou; Pei-Chun Chuang; Ying-Shun Wu; Jing-Jou Yan; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

10.  Characterization of Mycobacterium tuberculosis complex isolated from iranian and afghani patients by spoligotyping method.

Authors:  Rashid Ramazanzadeh; Parisa Farnia; Nour Amirmozafari
Journal:  Braz J Microbiol       Date:  2009-06-01       Impact factor: 2.476

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.